Acadian Asset Management LLC Has $135.10 Million Stock Position in The Clorox Company (NYSE:CLX)

Acadian Asset Management LLC raised its holdings in The Clorox Company (NYSE:CLX) by 26.5% in the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 882,526 shares of the company’s stock after acquiring an additional 184,847 shares during the quarter. Acadian Asset Management LLC owned approximately 0.71% of Clorox worth $135,099,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its position in Clorox by 0.3% in the 1st quarter. Vanguard Group Inc. now owns 15,277,580 shares of the company’s stock valued at $2,339,150,000 after acquiring an additional 48,632 shares during the period. Mitsubishi UFJ Trust & Banking Corp increased its position in Clorox by 24.3% in the 1st quarter. Mitsubishi UFJ Trust & Banking Corp now owns 181,772 shares of the company’s stock valued at $27,711,000 after acquiring an additional 35,477 shares during the period. First Foundation Advisors acquired a new position in Clorox in the 1st quarter valued at approximately $31,000. Mizuho Markets Americas LLC increased its position in Clorox by 93.7% in the 1st quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company’s stock valued at $11,032,000 after acquiring an additional 34,864 shares during the period. Finally, Wilkins Investment Counsel Inc. increased its position in Clorox by 51.6% in the 1st quarter. Wilkins Investment Counsel Inc. now owns 16,514 shares of the company’s stock valued at $2,528,000 after acquiring an additional 5,624 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Down 0.9 %

Shares of NYSE CLX traded down $1.17 during mid-day trading on Friday, reaching $135.14. 827,185 shares of the company’s stock traded hands, compared to its average volume of 1,166,653. The stock has a market cap of $16.78 billion, a P/E ratio of 70.02, a PEG ratio of 2.01 and a beta of 0.39. The business has a 50-day simple moving average of $134.20 and a 200 day simple moving average of $142.95. The Clorox Company has a 1-year low of $114.68 and a 1-year high of $169.14. The company has a debt-to-equity ratio of 9.73, a current ratio of 0.90 and a quick ratio of 0.53.

Clorox (NYSE:CLX) last released its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, beating analysts’ consensus estimates of $1.33 by $0.38. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The company had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same period last year, the firm earned $1.51 earnings per share. The firm’s revenue was down 5.3% on a year-over-year basis. On average, analysts expect that The Clorox Company will post 5.92 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on CLX shares. BNP Paribas started coverage on shares of Clorox in a research report on Monday, June 24th. They set an “underperform” rating and a $130.00 price objective for the company. Wells Fargo & Company decreased their price objective on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a research report on Wednesday, July 10th. UBS Group decreased their price objective on shares of Clorox from $164.00 to $159.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. Evercore ISI decreased their price objective on shares of Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a research report on Wednesday, May 1st. Finally, Barclays decreased their price objective on shares of Clorox from $132.00 to $122.00 and set an “underweight” rating for the company in a research report on Friday. Five equities research analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the company’s stock. According to MarketBeat.com, Clorox currently has an average rating of “Hold” and an average target price of $144.00.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.